Clincosm LogoSign in Get a demo

hepatocarcinoma

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

ful Mutations in Solid Tumor Characterized by Next Generation

Recruiting
  • Solid Tumor
  • +13 more
    • Aviano, Pordonone, Italy
      IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
    Sep 8, 2023

    Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic

    Recruiting
    • Hepatocarcinoma
    • Pancreatic Tumor
    • Hepatocellular carcinoma
    • +2 more
    • Clichy, France
      Hôpital Beaujon
    Mar 20, 2023

    Recurrence and Metastasis of Hepatocarcinoma Following Local

    Recruiting
    • Hepatocarcinoma
      • Guangzhou, Guangdong, China
      • +16 more
      Dec 22, 2022

      Hepatocarcinoma, Cholangiocarcinoma, Quality of Life Trial in Rozzano (Synchrolevels)

      Completed
      • Hepatocarcinoma
      • +2 more
      • Synchrolevels
      • Rozzano, Lombardia, Italy
        Humanitas Research Hospital
      Aug 2, 2022

      Hepatocarcinoma Trial in Shanghai (HAIC+TQB2450+Anlotinib)

      Recruiting
      • Hepatocarcinoma
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 27, 2022

      Hepatocarcinoma Trial in France (Intplex test)

      Active, not recruiting
      • Hepatocarcinoma
      • Intplex test
      • Montpellier, Hérault, France
      • +5 more
      Jan 25, 2022

      Multiple Myeloma, Refractory, Hepatocarcinoma, Advanced Solid Tumor Trial in Catanzaro (LNA-i-miR-221)

      Completed
      • Multiple Myeloma, Refractory
      • +2 more
      • LNA-i-miR-221
      • Catanzaro, Italy
        Center for Phase I Clinical Studies in Medical Oncology and Onco
      Jan 31, 2022

      Hepatocarcinoma Trial in France (Surgical planning)

      Completed
      • Hepatocarcinoma
      • Surgical planning
      • Clichy, France
      • +11 more
      Feb 9, 2021

      11C-Choline PET/CT and DWI MRI for Response Assessment of HCC

      Completed
      • Hepatocarcinoma
      • No intervention
      • Rozzano, Milano, Italy
        Istituto Clinico Humanitas
      Sep 29, 2020

      Hepatocarcinoma Trial in Rozzano (Cabozantinib 60 MG)

      Recruiting
      • Hepatocarcinoma
      • Cabozantinib 60 MG
      • Rozzano, Milano, Italy
        Istituto Clinico Humanitas
      Jun 15, 2020

      Hepatocarcinoma, Lung Cancer, Melanoma Trial in Guanzhou (Checkpoint inhibitor (CPI) such as Pembrolizumab)

      Recruiting
      • Hepatocarcinoma
      • +9 more
      • Checkpoint inhibitor (CPI) such as Pembrolizumab
      • Guanzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Feb 14, 2020

      Hepatocarcinoma, Hepatic Metastasis, Hepatic Tumor Trial in Paris (Confocal Laser Endomicroscopy)

      Unknown status
      • Hepatocarcinoma
      • +2 more
      • Confocal Laser Endomicroscopy
      • Paris, France
        Institut Mutualiste Montsouris
      Jan 23, 2019

      DwI-MR to Predict Chemotherapy Response of Liver Metastases and

      Completed
      • Liver Metastases
      • Hepatocarcinoma
        • Florence, Italy
          Stefano Colagrande
        Dec 9, 2014